Get started
Hemostemix IncHemostemix IncHemostemix Inc

Hemostemix Inc

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonals

HEM chart


Full chart

HEM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪20.24 M‬ CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.030 CAD
Net income (FY)
‪−2.62 M‬ CAD
Revenue (FY)
0.00 CAD
Shares float
‪146.16 M‬
Beta (1Y)
−0.15

About Hemostemix Inc


Sector
Health Technology
Industry
Biotechnology
CEO
Thomas A. Smeenk
Website
hemostemix.com
Headquarters
Calgary
Founded
2006
ISIN
CA4236943060
FIGI
BBG0038N5RC6
Hemostemix, Inc. is a clinical-stage biotechnology company, which is focused on developing and commercializing a proprietary autologous cell therapy to treat ischemic diseases. The firm's, ACP-01, lead clinical stage candidate, is an autologous cell therapy for the treatment of critical limb ischemia. The company was founded by Roger Bergersen and Thomas A. Smeenk in 2006 and is headquartered in Calgary, Canada.

Check out other big names from the same industry as HEM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

HEM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of HEM is 0.110 CAD — it has decreased by −4.35% in the past 24 hours. Watch Hemostemix Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange Hemostemix Inc stocks are traded under the ticker HEM.
HEM stock has risen by 10.00% compared to the previous week, the last month showed zero change in price, over the last year Hemostemix Inc has showed a 57.14% increase.
HEM reached its all-time high on Dec 24, 2014 with the price of 25.000 CAD, and its all-time low was 0.035 CAD and was reached on May 1, 2024. View more price dynamics on HEM chart.
See other stocks reaching their highest and lowest prices.
HEM stock is 13.64% volatile and has beta coefficient of −0.15. Track Hemostemix Inc stock price on the chart and check out the list of the most volatile stocks — is Hemostemix Inc there?
Today Hemostemix Inc has the market capitalization of ‪20.24 M‬, it has increased by 15.00% over the last week.
Yes, you can track Hemostemix Inc financials in yearly and quarterly reports right on TradingView.
Hemostemix Inc is going to release the next earnings report on Nov 26, 2025. Keep track of upcoming events with our Earnings Calendar.
HEM net income for the last quarter is ‪−307.65 K‬ CAD, while the quarter before that showed ‪−1.28 M‬ CAD of net income which accounts for 76.05% change. Track more Hemostemix Inc financial stats to get the full picture.
No, HEM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, HEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hemostemix Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hemostemix Inc technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hemostemix Inc stock shows the sell signal. See more of Hemostemix Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.